Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 17/20 | 0.47 |
| ▸ | MMP13 | P45452 | 16/20 | 0.47 |
| ▸ | MMP2 | P08253 | 3/20 | 0.42 |
| ▸ | MMP9 | P14780 | 3/20 | 0.42 |
| ▸ | MMP3 | P08254 | 2/20 | 0.42 |
| ▸ | MMP8 | P22894 | 2/20 | 0.42 |
| ▸ | MMP14 | P50281 | 2/20 | 0.42 |
| ▸ | MMP12 | P39900 | 1/20 | 0.42 |
| ▸ | SGMS1 | Q86VZ5 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7209180 | 0.92 | MMP1 (0.57) | MMP1MMP13MMP2MMP9MMP3 | |
| SCHEMBL25364 | 0.88 | MMP1 (0.52) | MMP1MMP13MMP2MMP9MMP3 | |
| SCHEMBL7213095 | 0.84 | MMP1 (0.49) | MMP1MMP13MMP2MMP9MMP3 | |
| SCHEMBL7208630 | 0.83 | MMP13 (0.56) | MMP1MMP13MMP2MMP9MMP14 | |
| SCHEMBL7208148 | 0.80 | MMP1 (0.52) | MMP1MMP13MMP2MMP9MMP3 | |
| SCHEMBL7208607 | 0.78 | MMP1 (0.52) | MMP1MMP13MMP2MMP9MMP3 | |
| SCHEMBL7209196 | 0.77 | MMP1 (0.53) | MMP1MMP13MMP2MMP9MMP3 | |
| SCHEMBL6953477 | 0.73 | MMP1 (0.83) | MMP1MMP13MMP2MMP9MMP3 | |
| SCHEMBL7209150 | 0.72 | MMP1 (0.78) | MMP1MMP13MMP2MMP9MMP3 | |
| SCHEMBL7137267 | 0.71 | MMP1 (0.59) | MMP1MMP13MMP2MMP9MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1181285-B1 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES | PFIZER PROD INC (US) | 2003-10-08 | — | — | EP | disclosed |
| EP-1181285-A2 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES | Pfizer Products Inc. (US) | 2002-02-27 | — | — | EP | disclosed |
| US-6342521-B1 | DRUGS FOR TREATMENT OF ARTHRITIS | PFIZER INC. | 2002-01-29 | — | — | US | disclosed |
| WO-2000073294-A2 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES | PFIZER PRODUCTS INC. (US) | 2000-12-07 | — | — | WO | disclosed |